Fig 1.
CONSORT diagram for European organisation for the research of cancer quality of life questionnaires C30 completed for the total number of eligible.
Table 1.
Demographic and clinical characteristics by gender and treatment arms.
Fig 2.
Overall survival by gender, Folfirinox arm.
Fig 3.
Overall survival by gender, ITT population.
Table 2.
Overall survival and progression-free survival by gender and treatment arm.
Table 3.
Prognostic factors for overall survival in FOLFIRINOX arm.
Univariate analysis.
Table 4.
Prognostic factors for overall survival in FOLFIRINOX arm.
Multivariable analysis.